Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) delivers transformative intelligence through market-leading platforms like Web of Science™ and Cortellis™, powering innovation across academia, intellectual property, and life sciences. This news hub provides investors and professionals with direct access to official announcements shaping global research and commercialization efforts.
Track critical updates including quarterly earnings disclosures, strategic partnerships, product launches, and regulatory filings. Our curated feed ensures timely access to press releases about AI-driven analytics advancements, IP portfolio developments, and expansions in pharmaceutical intelligence solutions.
Key content categories include financial performance reports, acquisition announcements, leadership updates, and innovations in real-world data applications. Bookmark this page to monitor Clarivate's progress in converting transactional revenues to high-margin subscriptions while maintaining its position as a critical enabler of R&D workflows.
Clarivate Plc (NYSE:CLVT) launched its Annual G20 Scorecard – Research Performance 2021 report, analyzing the research responses of G20 nations to COVID-19. The report reveals that nations with diverse research portfolios, like the US and Germany, are better equipped to address a wide array of COVID-19 challenges. Although Brazil shows strength in biosciences, others, like Mexico, experience declining research investment. The report highlights changes in research output and collaboration across nations, providing insights essential for policymakers and analysts ahead of the G20 Summit.
On October 18, 2021, Clarivate Plc (NYSE: CLVT) appointed Tiffani Shaw as Chief of Staff, effective November 1. In this new role, Shaw will manage administrative activities in the CEO's office and be part of the Executive Leadership Team. Previously, she was Executive VP and COO at the University of Iowa Center for Advancement, managing over $2 billion in assets. Shaw's experience includes roles as CFO and Controller, alongside a strong background in governance and strategic planning.
Clarivate Plc (NYSE: CLVT) celebrates the recognition of five new Nobel Laureates identified as Citation Laureates. This includes awards in Physiology or Medicine, Physics, Chemistry, and Economics, highlighting Clarivate's predictive accuracy since 2002. Notably, 64 Citation Laureates have received this honor, emphasizing the company's unique methodology combining quantitative data and expert analysis. The awards reflect significant contributions by researchers such as David Julius and Giorgio Parisi, showcasing Clarivate's role in advancing scientific recognition.
Clarivate Plc (NYSE: CLVT) announced it will release its third-quarter 2021 financial results on October 28, 2021, before the market opens. The press release and earnings information will be available on the company’s investor website. A conference call and webcast will follow at 8:00 AM Eastern Time the same day, providing insights into the financial results. Interested participants can join the call via phone or through the live webcast. An audio replay will be accessible after the call until November 11, 2021.
Clarivate Plc (NYSE:CLVT) released a Global Research Report analyzing the research landscape of 34 countries in South & Central America, Mexico, and the Caribbean since 1981. The report highlights a rapid growth in academic research output, particularly from South America, with over 25,000 papers published by five leading countries from 2016 to 2020. However, regional collaboration remains low, at about 10%. The report suggests establishing a regional research organization to enhance research capacity and collaboration, echoing successful European models. Key strengths include life sciences, environmental studies, and increasing international collaboration.
Clarivate Plc (NYSE: CLVT) has announced the 2021 Citation Laureates, recognizing 16 elite researchers for their exceptional contributions to science. This year's honorees come from the United States, Japan, France, Italy, Korea, and Singapore, selected based on citation analysis by the Institute for Scientific Information. Only 0.01% of articles indexed in the Web of Science have been cited over 2,000 times, highlighting the significance of these laureates' work. Historical data shows that 59 Citation Laureates have previously received a Nobel Prize.
On September 15, 2021, Clarivate Plc (NYSE: CLVT) announced the release of the 2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook. The report reveals a 10-year high for new molecular entities (NMEs), with 59 NMEs launched in 2020, indicating resilience amidst the COVID-19 pandemic. The Factbook offers insights on R&D expenditures, cycle times, and pipeline growth, helping pharma companies benchmark their efforts. Notably, CDC approval times remained stable, reflecting a consistent drug development landscape despite pandemic challenges.
Clarivate Plc (NYSE: CLVT) has announced the pricing of an underwritten public offering of 25,000,000 ordinary shares by affiliated funds of Onex Corporation and Baring Private Equity Asia. The offering is set to close on September 14, 2021, pending customary conditions. An additional 3,750,000 shares may be purchased at the underwriters' discretion. Clarivate will not sell any shares, with proceeds solely benefiting the Selling Shareholders. Citigroup and Barclays are acting as joint book-running managers for this offering.
On September 9, 2021, Clarivate Plc (NYSE: CLVT) announced an underwritten public offering of 25 million ordinary shares, managed by Citigroup and Barclays. The offering includes a 30-day option for underwriters to purchase an additional 3.75 million shares. The proceeds from this offering will be received entirely by the Selling Shareholders, Onex Corporation and Baring Private Equity Asia Group Ltd. The sale will occur under an effective shelf registration statement, and investors are encouraged to review all related documents filed with the SEC for complete information.
FAQ
What is the current stock price of Clarivate Plc (CLVT)?
What is the market cap of Clarivate Plc (CLVT)?
